Author:
Trojani M.C.,Gensburger D.,Bagouet F.,Cortet B.,Couture G.,Marcelli C.,Mehsen Cetre N.,Breuil V.,Chapurlat R.
Subject
Histology,Physiology,Endocrinology, Diabetes and Metabolism
Reference20 articles.
1. Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium;Javaid;Orphanet. J. Rare Dis. [Internet],2019
2. Activation of RANK/RANKL/OPG pathway is involved in the pathophysiology of fibrous dysplasia and associated with disease burden;de Castro;J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res.,2019
3. Fibrous dysplasia of bone and McCune-Albright syndrome: a bench to bedside review;Hartley;Calcif. Tissue Int.,2019
4. Fibrous dysplasia of bone;Chapurlat;Baillieres Best Pract. Res. Clin. Rheumatol.,2000
5. Denosumab for fibrous dysplasia: promising, but questions remain;Collins;J. Clin. Endocrinol. Metab.,2020
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献